IDEXX Laboratories
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $1,090,579 | $1,105,239 | $1,109,457 | $998,427 |
Gross Profit | 658,114 | 683,354 | 694,732 | 623,379 |
EBITDA | 356,219 | 392,053 | 409,445 | 351,813 |
EBIT | 317,498 | 355,426 | 373,673 | 317,750 |
Net Income | 248,188 | 274,610 | 293,989 | 242,677 |
Net Change In Cash | 1,090,579 | 1,105,239 | 1,109,457 | 998,427 |
Free Cash Flow | 322,588 | 371,226 | 151,641 | 207,936 |
Cash | 180,070 | 208,166 | 164,594 | 163,970 |
Basic Shares | 80,675 | 80,675 | 80,994 | 81,922 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,303,702 | $3,897,504 | $3,660,953 | $3,367,324 |
Gross Profit | 2,659,579 | 2,378,927 | 2,189,970 | 2,004,338 |
EBITDA | 1,468,916 | 1,275,840 | 1,097,128 | 1,010,665 |
EBIT | 1,362,454 | 1,145,904 | 1,097,128 | 898,765 |
Net Income | 1,059,464 | 887,867 | 845,042 | 679,089 |
Net Change In Cash | 4,303,702 | 3,897,504 | 3,660,953 | 3,367,324 |
Cost of Revenue | -23,302 | |||
Free Cash Flow | 1,053,391 | 798,079 | 772,879 | 394,146 |
Cash | 180,070 | 288,266 | 453,932 | 112,546 |
Basic Shares | 80,675 | 83,056 | 83,978 | 84,600 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $3.08 |
2025-09-30 | $3.40 |
2025-06-30 | $3.63 |
2025-03-31 | $2.96 |